What is Genfit S.A.?
, together with its subsidiaries, engages in the research and development of medicines and diagnostic solutions in France and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, together with its subsidiaries, engages in the research and development of medicines and diagnostic solutions in France and internationally. The company offers elafibranor for the treatment of primary biliary cholangitis; and NIS, a non-invasive diagnostic technology for the treatment of metabolic dysfunction-associated steatohepatitis. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 171.37M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.